SCHEMBL24543012

SCHEMBL24543012

COCc1ccc(-c2ccc(NC(=O)C(C)(C)Oc3ccc(C#N)cc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 6/20 0.53
▸ PPARD Q03181 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ SAE1 Q9UBE0 1/20 0.43
▸ UBA2 Q9UBT2 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ IL18 Q14116 1/20 0.43
▸ ADAMTS4 O75173 1/20 0.43
▸ MMP13 P45452 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24543016 0.87 PPARA (0.51) PPARAPPARDPOLBMAPTRAB9A
SCHEMBL24543063 0.86 PPARA (0.54) PPARAPOLBMAPTRAB9AKDM4E
SCHEMBL24543029 0.86 PPARA (0.50) PPARAPOLBRAB9AKDM4EMEN1
SCHEMBL24542787 0.86 PPARA (0.50) PPARAMAPTRAB9AMEN1LMNA
SCHEMBL24542755 0.85 CYP1A2 (0.60) PPARAPOLBMAPTKDM4EMEN1
SCHEMBL24542758 0.85 PPARA (0.52) PPARAPPARDMEN1LMNAKMT2A
SCHEMBL24542785 0.85 PPARA (0.49) PPARAPOLBMAPTKDM4EMEN1
SCHEMBL24542753 0.85 PPARA (0.57) PPARARAB9AMEN1KMT2ACYP1A2
SCHEMBL24543299 0.83 PPARA (0.54) PPARAPPARDMAPTLMNAPKM
SCHEMBL24543070 0.83 ALDH1A1 (0.48) PPARAPPARDRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4263492-B1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARM INC (US) 2025-04-09 — — EP disclosed
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARMACEUTICALS INC. 2024-04-25 — — US disclosed
WO-2022129933-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 Pandeia Therapeutics Limited (GB) 2022-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 GPR88, GPR65, GPR68 PPARA 355/4885PPARD 408/4885POLB 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback